Biological E Vaccine
- September 3, 2021
- Posted by: OptimizeIAS Team
- Category: DPN Topics
No Comments
Biological E Vaccine
Subject – Science and Tech
Context – Biological E gets nod for Phase II/III trials on kids
Concept –
- Hyderabad-based Biological E has received the nod to move ahead with its clinical trials for children’s vaccine.
- The company has the Drugs Controller General of India’s (DCGI) permission to conduct Phase II / III trials of its vaccine candidate on children in the age group of 5 to 18 years.
- The development comes even as ZydusCadila’s needle-free Plasmid DNA vaccine received emergency approvals recently for use in adults and children.
- Others in the fray running trials on Covid-19 vaccines inchildren or adolescents, as the case may be, include Bharat Biotech, Serum Institute (on the Novavax vaccine) and, more recently, Johnson and Johnson.
For more information on clinical trials, please refer to this – Clinical Trials.